Abstract

Ethical Viewpoint Paper_Failure Of Health Diplomacy To Communicate Covid-19: Political, Ethical, Legal And Medical Perspective

Highlights

  • A report from the German economic newspaper Handelsblatt's “Setback for vaccine” ran as its top story subtitled, “The AstraZeneca vaccine apparently has an effectiveness of only 8% in the elderly [11]

  • Just a few days later BBC reported that most adults under the age of 40 will be given an alternative to the Oxford-AstraZeneca vaccine due to its association with rare blood clots [12]

  • Canada and Germany joined Iceland, Sweden, Finland, and France in recommending against this vaccine's use in younger people, who seem to be at higher risk for developing the clot and are less likely to develop severe COVID-19

Read more

Summary

Introduction

While awareness of the side effects of vaccines grows, a bigger problem loomed as many millions have been depending on it. It's been one step forward, two back for AstraZeneca's COVID-19 vaccine [10]. Just a few days later BBC reported that most adults under the age of 40 will be given an alternative to the Oxford-AstraZeneca vaccine due to its association with rare blood clots [12].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call